Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial

BACKGROUND: Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18.8% in men and 9.4% in women. Given the high cost of medical treatments and surgical interventions as well as the morbidity related to symptomatic stone disease, medical prophylaxis for stone recurrence is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhayat, Nasser A., Faller, Nicolas, Bonny, Olivier, Mohebbi, Nilufar, Ritter, Alexander, Pellegrini, Lisa, Bedino, Giulia, Schönholzer, Carlo, Venzin, Reto M., Hüsler, Carina, Koneth, Irene, Del Giorno, Rosaria, Gabutti, Luca, Amico, Patrizia, Mayr, Michael, Odermatt, Urs, Buchkremer, Florian, Ernandez, Thomas, Stoermann-Chopard, Catherine, Teta, Daniel, Rintelen, Felix, Roumet, Marie, Irincheeva, Irina, Trelle, Sven, Tamò, Luca, Roth, Beat, Vogt, Bruno, Fuster, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288917/
https://www.ncbi.nlm.nih.gov/pubmed/30526528
http://dx.doi.org/10.1186/s12882-018-1144-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288917/
https://www.ncbi.nlm.nih.gov/pubmed/30526528
http://dx.doi.org/10.1186/s12882-018-1144-6

Ejemplares similares